SMS Pharmaceuticals Ltd.
BSE: 532815 | Sector: Health care |
NSE: SMSPHARMA | ISIN Code: INE812G01025 |
BSE 00:00 | 24 Mar | 63.87 |
-1.27 (-1.95%) |
OPEN
64.60 |
HIGH
65.00 |
LOW
63.25 |
NSE 00:00 | 24 Mar | 64.10 |
-0.80 (-1.23%) |
OPEN
64.90 |
HIGH
65.00 |
LOW
63.40 |
OPEN | 64.60 |
PREVIOUS CLOSE | 65.14 |
VOLUME | 4708 |
52-Week high | 114.90 |
52-Week low | 60.10 |
P/E | 106.45 |
Mkt Cap.(Rs cr) | 541 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
SMS Pharmaceuticals Ltd. (SMSPHARMA) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Sun Pharma.Inds. | 972.80 | -4.50 | -0.46 | 15585.98 |
Dr Reddy's Labs | 4462.30 | 14.35 | 0.32 | 14405.20 |
Cipla | 877.00 | 7.50 | 0.86 | 13091.79 |
Lupin | 639.75 | -8.75 | -1.35 | 11771.67 |
Aurobindo Pharma | 500.20 | 14.05 | 2.89 | 11287.14 |
Divi's Lab. | 2806.25 | 5.20 | 0.19 | 8879.82 |
Alkem Lab | 3151.40 | 2.50 | 0.08 | 8829.81 |
Glenmark Pharma. | 425.65 | -11.05 | -2.53 | 8141.58 |
Zydus Lifesci. | 480.50 | -1.85 | -0.38 | 7981.90 |
Torrent Pharma. | 1518.10 | -13.10 | -0.86 | 6742.32 |
Apollo Hospitals | 4281.20 | 10.10 | 0.24 | 6098.30 |
Ipca Labs. | 780.85 | -4.00 | -0.51 | 5399.36 |
Alembic Pharma | 484.45 | -4.50 | -0.92 | 5035.41 |
Abbott India | 21139.45 | -410.70 | -1.91 | 4919.27 |
Laurus Labs | 299.15 | -3.90 | -1.29 | 4707.04 |
Gland Pharma | 1283.25 | -11.40 | -0.88 | 4400.71 |
Granules India | 282.15 | 1.55 | 0.55 | 3238.44 |
Glaxosmi. Pharma | 1290.15 | -4.00 | -0.31 | 3217.51 |
Ajanta Pharma | 1182.05 | -48.75 | -3.96 | 3140.64 |
Piramal Pharma | 67.82 | -2.00 | -2.86 | 3094.95 |
Quick Links for SMS Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices